Abstract
Not only is chemo fog a troublesome medical problem for the sufferers, but in addition it is the source of nearly $300 million in direct and indirect expense in the United States alone each year. And since it often persists for extended periods of time, the indirect costs, which stem mainly from lost productivity, continue to accumulate with another nearly $250 million added to the overall cost each year. This is not the highest economic burden for common diseases, but it is a significant amount that could be mostly avoided if biomedical scientists were to find a means to employ safer chemotherapeutic agents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Apantaku LM. Breast cancer diagnosis and screening. American Family Physician 2000; 62(3):596–602 (Comment 605-606).
Breast cancer facts and figures, 2007–2008. American Cancer Society, p 2, Atlanta, 2007.
Phillips KA, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. Journal of the National Cancer Institute 2003; 95(3):190–197.
Taillibert S, Voillery D, Bernard-Marty C. Chemobrain: is systemic chemotherapy neurotoxic? Current Opinion in Oncology 2007; 19(6):623–627.
Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Current Opinion in Neurology 2007; 20(6):719–725.
Vardy J, Wefel JS, Ahles T et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Annals of Oncology 2008; 19(4):623–629.
Hess LM, Insel KC. Chemotherapy-related change in cognitive function: a conceptual model. Oncology Nursing Forum 2007; 34(5):981–994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Wertheimer, A.I. (2010). The Economic Burden. In: Raffa, R.B., Tallarida, R.J. (eds) Chemo Fog. Advances in Experimental Medicine and Biology, vol 678. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6306-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6306-2_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6305-5
Online ISBN: 978-1-4419-6306-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)